Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...

Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 ...

Dow Jones Top Company Headlines at 3 PM ET: Amazon to Invest $50 Billion Building Data Centers to Support U.S. Government | Scripps ... Amazon to Invest $50 Billion Building Data Centers to Support ...

Dow Jones Top Company Headlines at 9 AM ET: Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer's Trials | Performance ... Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer's ...

Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the ...

A new study reported that Novo Nordisk spent $7.5 million over 2 years on more than 15,000 internet keywords — many focused ...

Open enrollment runs from October 15 through December 7, giving beneficiaries a window in which to review options, including ...

Yet when it comes to producing the next generation of breakthrough medicines, US drugmakers and their patients appear poised to grow more, not less, dependent on Chinese innovation ...

Overindulging in rich foods while taking a drug like Wegovy or Zepbound can raise the risk of side effects like nausea and ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...